BlockBeats News, August 15th. Hong Kong-listed company Concord Medical (01931.HK) announced that due to the Board's belief that purchasing and holding cryptocurrency is an important measure for the Group to solidify its Ethereum (ETH) reserve fund and accelerate the development of the ivd.xyz trading platform's ecosystem, and is also an important part of the Group's asset allocation strategy, after careful consideration, the Board recommends seeking prior approval from the shareholders to grant a purchase authorization. This authorization will empower the Board to carry out potential cryptocurrency purchases over a period of 36 months starting from the date of the special shareholder meeting, with the total purchase amount not exceeding 3 billion Hong Kong dollars.